CLINICAL TRIAL PROTOCOL A randomized trial of AmBisome® monotherapy and combination of AmBisome® and miltefosine for the treatment of VL in HIV positive patients in Ethiopia followed by secondary VL prophylactic treat

First Page		Document Content
Date: 2014-10-14 06:11:40 Antiprotozoal agents Neglected diseases Antifungals Visceral leishmaniasis Leishmaniasis Miltefosine Amphotericin B Sodium stibogluconate Drugs for Neglected Diseases Initiative Medicine Microbiology Health		CLINICAL TRIAL PROTOCOL A randomized trial of AmBisome® monotherapy and combination of AmBisome® and miltefosine for the treatment of VL in HIV positive patients in Ethiopia followed by secondary VL prophylactic treat Add to Reading List Source URL: fieldresearch.msf.org Download Document from Source Website File Size: 578,67 KB Share Document on Facebook

	Annex 6 Costs of medicines in current use for the treatment of leishmaniasis Table A6.1. Drug prices (JanuaryCompound DocID: 142id - View Document
	DOI: BLL_2015_040 Bratisl Lek Listy 2015; – 206 CASE REPORT DocID: 12tUQ - View Document
	CLINICAL TRIAL PROTOCOL A randomized trial of AmBisome® monotherapy and combination of AmBisome® and miltefosine for the treatment of VL in HIV positive patients in Ethiopia followed by secondary VL prophylactic treat DocID: PGAx - View Document
	IOP Newsletter Contents V[removed] DocID: JjKC - View Document
	TropIKA_Review_VL_pdf_final DocID: 8x2C - View Document